New Century Infusion Solutions Brings Increased Efficiency, Cost Savings to Oncology Managed Care.BREA, Calif. -- New Century Infusion Solutions (NCIS NCIS Naval Criminal Investigative Service
NCIS National Coroners Information System (Australia)
NCIS Nebraska Career Information System
NCIS National Crime Intelligence Service
NCIS National Coalition of Independent Scholars ) launched today as the first Integrated Single Specialty Provider Integrated Single Specialty Provider is an example of an Integrated Single Specialty Provider organization. There is a published white paper that describes the use of ISSPs in the provision of oncology management. (ISSP ISSP Institute for Solid State Physics (University of Tokyo)
ISSP International Social Survey Programme
ISSP Intensive Supervision and Surveillance Programme (UK)
ISSP International Space Station Program ) focused on providing comprehensive management solutions to the oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors.
n. market. Designed to make oncology practices run more efficiently, NCIS is a cost-effective solution for payors and a valuable resource and advocate for oncologists and their very specific, complex needs.
NCIS bridges the gap between the disparate segments of oncology - the health plan, oncologists, and patients - to coordinate care, automate processes, optimize risk and reduce administrative burdens. By integrating and streamlining the management of oncology services, NCIS provides significant, often immediate cost savings for the payor and provider, and optimal quality of care for the patient.
"In the mature, yet highly fragmented oncology market, NCIS is the first and only comprehensive solutions provider that assumes full capitation CAPITATION. A poll tax; an imposition which is yearly laid on each person according to his estate and ability.
2. The Constitution of the United States provides that "no capitation, or other direct tax, shall be laid, unless in proportion to the census, or and global risk management. As the industry's first Integrated Single Specialty Provider - or ISSP - NCIS manages all three complicated, yet integral pieces, for the health plan and individual oncologist Oncologist
A physician specializing in the diagnosis and treatment of cancer
Mentioned in: Retinoblastoma
oncologist - the medical, radiation/technical and drug components," said Joseph Perez, founder and chief executive officer of NCIS. "In a world where claims processing and referrals typically take weeks, now instant authorizations, referrals and timely payments to the providers are a reality."
With NCIS both payor and provider will realize immediate and long-term benefits, including:
* Instant savings to oncology risks and halted oncology drug inflationary in·fla·tion·ar·y
Of, associated with, or tending to cause inflation: inflationary prices; inflationary policies.
Adj. 1. trends in the long-term.
* A dedicated team of full-time oncology specialists to assist in the whole continuum of oncology services.
* Reduced administrative burdens.
* Integrated medication management.
* Timely referrals and payments for services.
A Closer Look: Cancer Statistics
About 1.4 million cancer cases are expected to diagnose diagnose /di·ag·nose/ (di´ag-nos) to identify or recognize a disease.
1. To distinguish or identify a disease by diagnosis.
2. in 2007. This year alone, more than half a million people will die from the disease. Cancer is the second-leading cause of death, exceeded only by heart disease in the U.S. The National Institutes of Health (NIH "Not invented here." See digispeak.
NIH - The United States National Institutes of Health. ) estimates overall costs for cancer in 2006 at $206.3 billion: $78.2 for direct medical costs, $17.9 for indirect morbidity morbidity /mor·bid·i·ty/ (mor-bid´it-e)
1. a diseased condition or state.
2. the incidence or prevalence of a disease or of all diseases in a population.
n. costs, and $110.2 billion for indirect mortality costs. These costs are partially due to the complexities of oncology and the various players that must be coordinated to make decisions about a patient's care.
"Managed care organizations (MCOs) must coordinate care for all disease states and therefore they are 'jack of all trades,' or generalists. However, in order to provide focused management of a complex disease such as oncology, objective specialists are necessary and that's where an ISSP like NCIS comes in," said Chris Nee, Pharm.D., chief operating officer Chief Operating Officer (COO)
The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of NCIS. "We are focused 100 percent on the cost-effective provision of quality oncology services for all stakeholders Stakeholders
All parties that have an interest, financial or otherwise, in a firm-stockholders, creditors, bondholders, employees, customers, management, the community, and the government. . NCIS strives to optimize efficiencies in the oncology sector that will allow physicians to spend less time on administrative tasks and minimizing risks so they can focus on what's really important: providing optimal, appropriate care to patients."
About New Century Infusion Solutions (NCIS)
Headquartered in Brea, Calif., NCIS is the first and only Single Specialty Provider (ISSP) that provides a participatory environment where providers and payors can realize cost-effective, appropriate care and achieve the best possible outcomes for patients. With its comprehensive best-in-breed solutions focused on professional, pharmacy and global risk management, NCIS "connects the dots" to manage all the intricacies of oncology and navigates the highly complex market with an inside out evidence-based approach. NCIS is designed to work with physicians, not against them. In a world where claims processing and referrals typically take weeks, under the NCIS model, now instant authorizations, referrals and timely payments are a reality. Always with the end-goal of optimal, appropriate patient care in mind, NCIS is the first, true bridge between the payor, the provider and the patient. For more information, visit www.newcenturyinfusionsolutions.com or call 1-888-999-7713.
To order a copy of Oncology Drug Management: A White Paper on Marketplace Challenges, Opportunities and Strategies, by Chris Nee, Pharm.D., M.B.A., and chief operating officer of New Century Infusion Solutions, visit www.aishealth.com/Products/odm.html.